Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha.

Miyazaki, Masahito; Nishimura, Mio; Toda, Yoshihiro; Saijo, Takahiko; Mori, Kenji; Kuroda, Yasuhiro

Miyazaki, Masahito; Nishimura, Mio; Toda, Yoshihiro; Saijo, Takahiko; Mori, Kenji; Kuroda, Yasuhiro.

Affiliation

Miyazaki M; Department of Pediatrics, School of Medicine, University of Tokushima, Tokushima, Japan. mat@lilac.ocn.ne.jp

Brain Dev ; 27(4): 301-3, 2005 Jun.

Article in En | MEDLINE | ID: mdl-15862195

Subject(s)

Immunologic Factors/administration & dosage; Interferon-alpha/administration & dosage; Subacute Sclerosing Panencephalitis/drug therapy; Adolescent; Adult; Brain/pathology; Child; Disease Progression; Follow-Up Studies; Humans; Injections, Spinal; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Subacute Sclerosing Panencephalitis / Interferon-alpha / Immunologic Factors Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Humans / Male Language: En Journal: Brain Dev Year: 2005 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links